Fundraising FoxOrigami Surgical
Madison, US · Founded 2020 · Delaware corporation
Find your way into Origami Surgical
71 people in our graph can introduce you to the Origami Surgical team.
Sign up to see every warm intro you have to Origami Surgical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Origami Surgical team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Origami Surgical makes StitchKit, a product for robotic surgery that addresses exposed needle transfer to reduce lost sharps and near-miss sharps events. It targets surgical facilities and surgeons performing robotic procedures, aiming to improve patient safety and operating room efficiency.
Founders & leadership
JH
John HironimusCEO, Board MemberJohn Hironimus is CEO of Origami Surgical, which develops StitchKit, a robotic surgery technology that improves needle management and disposal in operating rooms. He brings over 20 years of experience in the medical device industry.
PC
Patrick CulliganNamed on SEC filing
SM
Sean McNerneyNamed on SEC filing
Board
Reported raises · per SEC filings
Form D private placements$6.8M disclosed across 5 rounds · 2020–2025
▶$450KraisedJul 2025 · 6 investors · OtherRule 506(b)
▶$450KraisedJul 2025 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Scott FloraDirector
- Marc BeerExecutive Officer, Director, Promoter
- Joseph L. LeeDirector
- Patrick Culligan, M.D.Executive Officer, Director, Promoter
- John HironimusExecutive Officer, Director
- Offering amount
- $1000K
- Amount sold
- $450K
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedNov 2024 · 6 investors · OtherRule 506(b)
▶$1.5MraisedNov 2024 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Patrick CulliganExecutive Officer, Director
- Marc BeerExecutive Officer, Director
- John HironimusExecutive Officer, Director
- Joseph LeeDirector
- Scott FloraDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.4MraisedDec 2023 · 6 investors · OtherRule 506(b)
▶$1.4MraisedDec 2023 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- John HironimusExecutive Officer, Director
- Patrick CulliganExecutive Officer, Director
- Marc BeerExecutive Officer, Director
- Joseph L. LeeDirector
- Scott FloraDirector
- Offering amount
- $2.1M
- Amount sold
- $1.4M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.3MraisedJul 2022 · 3 investors · OtherRule 506(b)
▶$1.3MraisedJul 2022 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Marc BeerExecutive Officer, Director
- Sean McNerneyExecutive Officer, Director
- Joseph LeeDirector
- Patrick CulliganExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.2MraisedApr 2020 · 2 investors · OtherRule 506(b)
▶$2.2MraisedApr 2020 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Marc BeerExecutive Officer, Director
- Patrick CulliganExecutive Officer, Director
- Joseph LeeDirector
- Sean McNerneyExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.2M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Origami Therapeutics, Inc.Origami Therapeutics is a preclinical-stage biopharmaceutical company developing protein degrader therapeutics to treat neurodegenerative diseases, starting with Huntington's disease. The company uses a proprietary platform that harnesses the body's natural protein disposal system to degrade disease-causing proteins.
Companies working in the same space as Origami Surgical.
Frequently asked questions
- What does Origami Surgical do?
- Origami Surgical makes StitchKit, a product for robotic surgery that addresses exposed needle transfer to reduce lost sharps and near-miss sharps events. It targets surgical facilities and surgeons performing robotic procedures, aiming to improve patient safety and operating room efficiency.
- How much funding has Origami Surgical raised?
- Origami Surgical has disclosed $6.8M raised across 5 rounds.
- Where is Origami Surgical headquartered?
- Origami Surgical is headquartered in Madison, US.